Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuma Wada

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 18, 2022
A transcriptomic signature that predicts cancer recurrence after hepatectomy in patients with colorectal liver metastasesYuma Wada, Mitsuo Shimada, Yuji Morine, et al.
World Journal of Surgical Oncology|November 23, 2024
Feasibility of robot-assisted surgery for defining circumferential resection margins for rectal cancer: a retrospective studyToshihiro Nakao, Mitsuo Shimada, Takuya Tokunaga, et al.
World Journal of Surgical Oncology|September 8, 2020
HIF-1α expression in liver metastasis but not primary colorectal cancer is associated with prognosis of patients with colorectal liver metastasisYuma Wada, Yuji Morine, Satoru Imura, et al.
BMC Surgery|February 23, 2024
Preoperative evaluation to determine the difficulty of No. 6 lymphadenectomy in laparoscopic gastrectomyChie Takasu, Masaaki Nishi, Kozo Yoshikawa, et al.
World Journal of Surgery|April 16, 2026
Conversion Surgery Following Combination Treatment With Immune Checkpoint Inhibitors and Chemotherapy for Initially Unresectable Gastric CancerMasaaki Nishi, Yuma Wada, Chie Takasu, et al.
Diseases of the Colon and Rectum|April 21, 2026
Exosomal miRNA Predicts Response to Preoperative Chemoradiotherapy in Locally Advanced Rectal CancerYuma Wada, Masaaki Nishi, Takayuki Noma, et al.
NPJ Precision Oncology|June 29, 2026
GLP-1 receptor agonist targets an AMPKα1-HIF1α-PFKFB3 metabolic vulnerability and enhances Lenvatinib response in hepatocellular carcinomaTakayuki Noma, Yuan Li, Yuma Wada, et al.
Surgery Today|February 8, 2019
The protective effect of epigallocatechin 3-gallate on mouse pancreatic islets via the Nrf2 pathwayYuma Wada, Atsushi Takata, Tetsuya Ikemoto, et al.
British Journal of Cancer|January 26, 2022
A blood-based noninvasive miRNA signature for predicting survival outcomes in patients with intrahepatic cholangiocarcinomaYuma Wada, Mitsuo Shimada, Yuji Morine, et al.
Surgery Today|February 26, 2026
The transanal approach for lower rectal cancer: a propensity score-matched analysisDaichi Ishikawa, Takuya Tokunaga, Hideya Kashihara, et al.
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|January 18, 2022
A transcriptomic signature that predicts cancer recurrence after hepatectomy in patients with colorectal liver metastasesYuma Wada, Mitsuo Shimada, Yuji Morine, et al.
World Journal of Surgical Oncology|November 23, 2024
Feasibility of robot-assisted surgery for defining circumferential resection margins for rectal cancer: a retrospective studyToshihiro Nakao, Mitsuo Shimada, Takuya Tokunaga, et al.
World Journal of Surgical Oncology|September 8, 2020
HIF-1α expression in liver metastasis but not primary colorectal cancer is associated with prognosis of patients with colorectal liver metastasisYuma Wada, Yuji Morine, Satoru Imura, et al.
BMC Surgery|February 23, 2024
Preoperative evaluation to determine the difficulty of No. 6 lymphadenectomy in laparoscopic gastrectomyChie Takasu, Masaaki Nishi, Kozo Yoshikawa, et al.
World Journal of Surgery|April 16, 2026
Conversion Surgery Following Combination Treatment With Immune Checkpoint Inhibitors and Chemotherapy for Initially Unresectable Gastric CancerMasaaki Nishi, Yuma Wada, Chie Takasu, et al.
Diseases of the Colon and Rectum|April 21, 2026
Exosomal miRNA Predicts Response to Preoperative Chemoradiotherapy in Locally Advanced Rectal CancerYuma Wada, Masaaki Nishi, Takayuki Noma, et al.
NPJ Precision Oncology|June 29, 2026
GLP-1 receptor agonist targets an AMPKα1-HIF1α-PFKFB3 metabolic vulnerability and enhances Lenvatinib response in hepatocellular carcinomaTakayuki Noma, Yuan Li, Yuma Wada, et al.
Surgery Today|February 8, 2019
The protective effect of epigallocatechin 3-gallate on mouse pancreatic islets via the Nrf2 pathwayYuma Wada, Atsushi Takata, Tetsuya Ikemoto, et al.
British Journal of Cancer|January 26, 2022
A blood-based noninvasive miRNA signature for predicting survival outcomes in patients with intrahepatic cholangiocarcinomaYuma Wada, Mitsuo Shimada, Yuji Morine, et al.
Surgery Today|February 26, 2026
The transanal approach for lower rectal cancer: a propensity score-matched analysisDaichi Ishikawa, Takuya Tokunaga, Hideya Kashihara, et al.
Pageof 11